Aktienanalyse zu Scienture Holdings Inc (MEDS)MEDSScienture Holdings Inc

DataMeds AI, Inc., formerly Wellgistics Health, Inc., is a holding company. It is engaged in health information technology (IT) that focuses on the vertical integration of technology, pharmacy, pharmaceutical-adjacent and telemedicine business units. The Company conducts its business through two wholly owned subsidiaries, Wood Sage, LLC and Wellgistics LLC, and two indirect subsidiaries, Alliance Pharma Solutions, LLC and Community Specialty Pharmacy, LLC. It is focused on improving the lives of patients while delivering solutions for pharmacies, providers, pharmaceutical manufacturers, and payors. Its technology platform, DelivMeds, serves as a pharmacy hub and allows clinical services to be connected to its health pharmacy operations. This platform will allow for an end-to-end mobile application solution whereby patients can digitize their prescription journey. The solution helps to preserve patient autonomy, prescription price transparency, and provide additional concierge services. It operates in the Healthcare sector (WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRI industry).

TRxADE Health Inc is not a good buy right now due to its significant losses and declining performance. The current price is $0.96, which reflects a staggering year-to-date change of -72.71%. Additionally, the forward P/E ratio is 0, indicating no expected earnings growth, and the gross margin is a concerning -9.80% as of Q2 2026. The main risk is the company's negative net income, which reached -$18,363,225 in Q2 2026, highlighting ongoing financial instability.